Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.
Alfredo Lorenzo, Bruce A. Yankner · Proceedings of the National Academy of Sciences · 1994
beta-Amyloid (beta A) is normally produced as a nontoxic soluble peptide. In Alzheimer disease, beta A aggregates and accumulates in the brain as inert diffuse plaques or compact plaques associated with neurodegenerative changes. To determine the relationship of neurotoxicity to the physical state of beta A, we created (i) nonamyloidogenic amorphous aggregates of beta A [amorphous beta A (Am-beta A)] analogous to diffuse plaques and (ii) amyloidogenic fibrils of beta A [fibrillar beta A (Fib-beta A)] analogous to compact plaques. In primary rat hippocampal culture, Fib-beta A was neurotoxic, whereas Am-beta A was not toxic. Fib-beta A caused significant loss of synapses in viable neurons, while Am-beta A had no effect on synapse number. The amyloid fibril-binding dye Congo red inhibited Fib-beta A neurotoxicity by inhibiting fibril formation or by binding to preformed fibrils. Congo red also inhibited the pancreatic islet cell toxicity of diabetes-associated amylin, another type of amyloid fibril. These results indicate that beta A neurotoxicity requires fibril formation. These findings and our previous demonstration that amylin fibrils are toxic suggest that a common cytopathic effect of amyloid fibrils may contribute to the pathogenesis of Alzheimer disease and other amyloidoses.
Cited by 1,324 works. doi:10.1073/pnas.91.25.12243
Authors
References
- Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein
- The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
- Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids
- Amyloid β-peptide is produced by cultured cells during normal metabolism
- Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels.
- Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
- Production of the Alzheimer Amyloid β Protein by Normal Proteolytic Processing
- Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment
- Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state
- Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease.